Smoking Status shows no Impact on the Treatment Response with Adalimumab in Patients with Hidradenitis suppurativa - Results from the German Hidradenitis Suppurativa Registry HSBest

被引：0

作者：

Kirsten, Natalia ^{[1
]}

Ohm, Frenz ^{[1
]}

Gehrdau, Kathrin ^{[1
]}

Stephan, Brigitte ^{[2
]}

Ben-Anaya, Nesrine ^{[2
]}

Pinter, Andreas ^{[3
]}

Bechara, Falk ^{[4
]}

Presser, Dagmar ^{[5
]}

Zouboulis, Christos ^{[6
]}

Podda, Maurizio ^{[7
]}

Augustin, Matthias ^{[1
]}

机构：

[1] Inst Versorgungsforsch Dermatol & bei Pflegeberuf, Hamburg, Germany

[2] Univ Klinikum Hamburg Eppendorf, Inst Versorgungsforsch Dermatol & bei Pfelegeberu, Hamburg, Germany

[3] Univ Klinikum Frankfurt, Klin Dermatol Venerol & Allergol, Frankfurt, Germany

[4] Ruhr Univ Bochum, Klin Dermatol Venerol & Allergol, Bochum, Germany

[5] Univ Wurzburg UKW, Klin Dermatol Venerolo & Allergol, Wurzburg, Germany

[6] Med Hsch Brandenburg Theodor Fontane, Hsch klin Dermatol Venerol & Allergol, Dessau, Germany

[7] Klinikum Darmstadt, Klin Dermatol, Darmstadt, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P186

引用

页码：114 / 115

页数：2

共 50 条

[41] Case of bullous pemphigoid under treatment with adalimumab for hidradenitis suppurativa
Sugaya, Makoto
Ishii, Mitsuko
Takahashi-Shishido, Naomi
Ichimura, Yohei
Morimura, Sohshi
JOURNAL OF DERMATOLOGY, 2021, 48 (04): : E163 - E164
[42] Hidradenitis suppurativa in a patient with Warkany syndrome: Sustainability of adalimumab treatment
Atzori, Laura
Bonato, Filippo
Pilloni, Luca
Rongioletti, Franco
DERMATOLOGIC THERAPY, 2020, 33 (01)
[43] HIDRADENITIS SUPPURATIVA. RESPONSE TO TREATMENT WITH INFLIXIMAB
Pedraz, J.
Dauden, E.
Perez-Gala, S.
Goiriz-Valdes, R.
Fernandez-Penas, P.
Garcia-Diez, A.
ACTAS DERMO-SIFILIOGRAFICAS, 2007, 98 (05): : 325 - 331
[44] Smoking Cessation and Hidradenitis Suppurativa: Advances and Treatment Gaps
Charrow, Alexandra
Barnes, Leandra A.
JAMA DERMATOLOGY, 2024,
[45] The impact of adalimumab on the intimacy of hidradenitis suppurativa patients: Experience of a dermatology unit in Portugal
Caldas, Regina
Almeida, Filipa Tavares
Guimaraes, Maria Jose
Lopes, Ana Gabriela
Pereira, Teresa
Brito, Celeste
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB101 - AB101
[46] Real-world experience of adalimumab in the treatment of hidradenitis suppurativa
Khosravi, Hasan
Anderson, Alyce M.
Kettering, Caroline
Mizes, Alicia
Patton, Timothy
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (05) : 1406 - 1409
[47] Efficacy results using a novel hidradenitis suppurativa endpoint, HiSCR (hidradenitis suppurativa clinical response), from the placebo-controlled phase of a phase 2 adalimumab study
Jemec, Gregor
Sobell, Jeffrey
Scheinfeld, Noah
Sood, Sarika
Gu, Yihua
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB42 - AB42
[48] Efficacy Results Using a Novel Hidradenitis Suppurativa Endpoint, Hiscr (Hidradenitis Suppurativa Clinical Response), From The Placebo-Controlled Phase of a Phase 2 Adalimumab Study
Scheinfeld, N. S.
Sobell, J. M.
Gu, Y.
Sood, S.
ANNALS OF EMERGENCY MEDICINE, 2013, 62 (04) : S151 - S151
[49] Treatment of Moderate to Severe Hidradenitis Suppurativa RESPONSE
Kimball, Alexa B.
Gu, Yihua
Okun, Martin
ANNALS OF INTERNAL MEDICINE, 2013, 159 (01) : 72 - 73
[50] RESIDUAL BURDEN IN ADALIMUMAB-TREATED PATIENTS WITH HIDRADENITIS SUPPURATIVA
Kimball, A. B.
Tran, T.
Friesen, D.
Shang, A.
Pansar, I
Oh, T.
Aleshin, M. A.
VALUE IN HEALTH, 2024, 27 (06) : S131 - S131

← 1 2 3 4 5 →